Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Pearce

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of the American College of Cardiology|October 12, 2000
How deadly is the "deadly quartet"? A post-CABG evaluationD L Sprecher, G L Pearce
Osteoarthritis and Cartilage|September 25, 2010
Statistical evaluation of biomedical studiesG L Pearce, D D Frisbie
Journal of the American Medical Directors Association|June 19, 2003
Front line workers in long-term care: the effect of educational interventions and stabilization of staffing ratios on turnover and absenteeismM A Noel, G L Pearce, R Metcalf
Drug Safety|August 28, 2001
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoringD Layton, G L Pearce, S A Shakir
European Journal of Clinical Pharmacology|January 1, 1995
Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoringK Kubota, G L Pearce, W H Inman
Journal of Psychopharmacology (Oxford, England)|February 24, 2001
Adverse effects associated with the use of donepezil in general practice in EnglandN R Dunn, G L Pearce, S A Shakir
Journal of Clinical Epidemiology|January 1, 1990
Prescription-event monitoring: methodology and recent progressN S Rawson, G L Pearce, W H Inman
BMJ (Clinical Research Ed.)|June 17, 2000
Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleedingN R Dunn, G L Pearce, S A Shakir
British Journal of Clinical Pharmacology|March 12, 1999
Cough and angiotensin II receptor antagonists: cause or confounding?F J Mackay, G L Pearce, R D Mann
Journal of Human Hypertension|March 18, 2006
A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patientsA G Johnson, G L Pearce, T M Danoff
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of the American College of Cardiology|October 12, 2000
How deadly is the "deadly quartet"? A post-CABG evaluationD L Sprecher, G L Pearce
Osteoarthritis and Cartilage|September 25, 2010
Statistical evaluation of biomedical studiesG L Pearce, D D Frisbie
Journal of the American Medical Directors Association|June 19, 2003
Front line workers in long-term care: the effect of educational interventions and stabilization of staffing ratios on turnover and absenteeismM A Noel, G L Pearce, R Metcalf
Drug Safety|August 28, 2001
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoringD Layton, G L Pearce, S A Shakir
European Journal of Clinical Pharmacology|January 1, 1995
Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoringK Kubota, G L Pearce, W H Inman
Journal of Psychopharmacology (Oxford, England)|February 24, 2001
Adverse effects associated with the use of donepezil in general practice in EnglandN R Dunn, G L Pearce, S A Shakir
Journal of Clinical Epidemiology|January 1, 1990
Prescription-event monitoring: methodology and recent progressN S Rawson, G L Pearce, W H Inman
BMJ (Clinical Research Ed.)|June 17, 2000
Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleedingN R Dunn, G L Pearce, S A Shakir
British Journal of Clinical Pharmacology|March 12, 1999
Cough and angiotensin II receptor antagonists: cause or confounding?F J Mackay, G L Pearce, R D Mann
Journal of Human Hypertension|March 18, 2006
A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patientsA G Johnson, G L Pearce, T M Danoff
Pageof 5